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Mechanical allodyniaPostoperative pain and its control remain one of the most important issues in the ﬁeld of surgery and health
care systems. Morphine is a potent and effective analgesic, but substance abuse patients can manifest cross-
tolerance to it, making it difﬁcult to satisfy their analgesic/anesthetic requirements. As carbamazepine has
shown antinociceptive properties in a variety of experimental and clinical settings, in the present study,
we evaluated its potential antiallodynic effects on postoperative pain in naïve and morphine-dependent
rats. Male rats were assigned to morphine-dependent and naïve groups and received intraperitoneally
drug vehicles as control group, 3 mg/kg morphine, 5, 10 or 15 mg/kg carbamazepine or 5 mg/kg carbamaze-
pine plus 3 mg/kg morphine as a combination therapy 2 and 24 h after surgery. Morphine-dependency was
induced with multiple doses of morphine administered i.p. and plantar incision was made on the hind paw to
simulate the postoperative pain. Paw withdrawal threshold (PWT) was obtained by von Frey ﬁlaments every
30 min after drug injection for up to 180 min. Morphine at 3 mg/kg exerted antiallodynic effects in naïve rats
and a decreased antinociception was observed in morphine-dependent rats. In contrast, 5 mg/kg carbamaz-
epine did not signiﬁcantly alter PWT in naives but it was effective in dependent rats. 10 and 15 mg/kg carba-
mazepine attenuated allodynia following surgery in both groups. Co-administration of 5 mg/kg
carbamazepine with 3 mg/kg morphine produced higher analgesia in morphine-dependent incised rats
and prolonged antinociception as compared to morphine alone (Pb0.05). Thus carbamazepine may potenti-
ate the analgesic effect of chronically administered morphine on postoperative pain model in morphine-
dependent rats.
© 2011 Published by Elsevier B.V.1. Introduction
Postoperative pain is a common type of pain (Sabetkasaei and
Rezai Gharai, 2006) and one out of every two patients experiences in-
tense or very intense pain during the ﬁrst few days post-surgery
(Whiteside et al., 2004). Postoperative care involves pain manage-
ment, prevention and treatment of postoperative complications and
recovery of function (Gilron, 2006). Injury and/or inﬂammation in pe-
ripheral tissues after surgery produces sensory changes resulting in
prolonged pain, increased sensitivity to painful stimuli (hyperalgesia)
and/or pain following innocuous stimulation (allodynia) (Girard et
al., 2004). The standard treatment of severe postoperative pain is
the use of opiates, which are also frequently abused. Morphine, a po-
tent analgesic and mu receptor agonist, can cause physicalnter & Department of Pharma-
Medical Sciences, Evin, Tehran,
8 21 23872539; fax: +98 21
i), fkasaei@yahoo.com
i), Elhams77@yahoo.com
sevier B.V.dependence (Chisholm-Burns et al., 2007) and patients with mor-
phine dependence can manifest cross-tolerance to other drugs, mak-
ing it difﬁcult to predict analgesic or anesthetic requirements
(Katzung et al., 2007).
In the formalin induced model of pain, morphine-dependent rats
experience signiﬁcantly more severe pain behavior after incision
compared to naïve rats (Rezai and Sabetkasaei, 2001) and that such
pain can be poorly controlled with morphine administration. Thus,
in order to boost the analgesia induced by morphine, co-
administration of another agent able to produce analgesia by a differ-
ent mechanism of action is often attempted (Girard et al., 2004).
Anticonvulsant agents, including carbamazepine, exert multiple
pharmacological actions (Perucca, 2005). Carbamazepine has proved
useful in managing trigeminal neuralgia and neuropathic pain
(Gilron, 2006). Surgical nerve injury is indeed an important cause of
neuropathic pain although mechanisms of postoperative and neuro-
pathic pains are usually different. However, they share several simi-
larities; the initiation and maintenance of both often involve
sensitization of primary afferent and second-order dorsal horn neu-
rons (Gilron, 2006; Woolf and Chong, 1993), both often manifest by
hyperalgesia and allodyina at or near the affected sites (Coderre et
al., 1993) and furthermore, excitatory amino acids such as glutamate
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nisms possibly involved in the modulation of postoperative pain by
carbamazepine include Na+ and Ca 2+ channel blockade and sup-
pression of glutamate release or an action on NMDA/AMPA receptors
(Brennan et al., 2005; Gilron, 2006). One study suggested that carba-
mazepine suppresses either opioid tolerance or opioid withdrawal
(Zullino et al., 2004).
Considering the high prevalence of morphine-dependency and the
challenges in managing postoperative pain in such states, the present
study aimed to evaluate the effect of carbamazepine on morphine in-
duced analgesia on postoperative pain in naïve and morphine-depen-
dent rats.
2. Materials and methods
2.1. Animals
Experiments on rats were approved by the ethical committee of
Neuroscience Research Center of Shahid Beheshti University of Med-
ical Sciences (Under the item: NRC-944). Male Wistar rats weighing
180–250 g were housed in groups of four under standard conditions
with unrestricted access to food and water. Rats were housed in the
room where the experimental procedure was to be performed in
order to minimize the stress response to novel environmental cues.
Animals were kept at a constant ambient temperature (24±1 °C)
under a 12-h light/dark cycle. All experiments were conducted
according to the guidelines for investigation of experimental pain in
conscious animals (Zimmermann, 1983).
2.2. Drugs
Morphine sulfate was obtained from Temad Iran Company (Iran)
and dissolved in 0.9% physiological saline. Carbamazepine was sup-
plied by Sobhan Darou Pharmaceutical (Iran) and suspended in 8 ml
of propylene glycol and 2 ml of 3% Tween 80 solutions (Sakaue et
al., 2005). Both drugs were administered intraperitoneally (i.p.) in a
volume of 0.1 ml/100 gr.
2.3. Study design
2.3.1. Study groups
Experiments were conducted in 2 separate groups, including
morphine-dependent and naïve rats which were further divided
into 6 subgroups according to the drugs and the doses administered.
All drugs were administered i.p. 2 and 24 h after intraplantar incision
surgery.
Rats in both groups received either morphine 3 mg/kg, carbamaz-
epine 5, 10 or 15 mg/kg, a combination of morphine3mg/kg with car-
bamazepine5mg/kg or drug vehicles (as control group). Vehicles
included normal saline and propylene glycol–tween and were admin-
istered in control groups at the same volume as the treatment groups.
2.3.2. Study procedure
At the beginning, motor activity of all animals was assessed using
rotarod test and the time duration they could keep coordination on
rotating rod was recorded. Paw withdrawal threshold (PWT) was
measured prior to the surgery as baseline and repeated 2 and 24 h fol-
lowing surgery (day 0 and 1). Immediately after the test procedure
and 24 h after surgery drugs were administered, and then mechanical
allodynia was assessed every 30 min up to 3 h at both days.
2.4. Induction of morphine-dependency
To induce morphine dependency, morphine solution was injected
i.p. for 4 successive days. For the ﬁrst two days, injections were made
3 times a day (8:30, 12:30, and 16:30 h), the ﬁrst dose being 5 mg/kg,second dose 5 mg/kg and third dose 7.5 mg/kg at day 1; while these
doses were respectively 7.5, 7.5 and 10 mg/kg on day 2. On day 3,
morphine 10 mg/kg was injected twice at 8:30 and 16:30 h. Finally
at day 4, morphine was injected 5 mg/kg as a single dose, and follow-
ing a lapse of 120 min, the experiment was started. Naïve rats re-
ceived saline for 4 days. On the fourth day, all animals could be
operated as morphine-dependent rats and 120 min post-surgery,
allodynia was evaluated. To verify the induction of morphine-
dependency on the fourth day, naloxone 5 mg/kg (i.p.) was injected
to a test batch and withdrawal symptoms including diarrhea, abdom-
inal cramps, and occasionally jumping were assessed. This batch of
animals was not further used in the study.
2.5. Postoperative pain model
The surgical method of Brennan et al. (1996) was used. Animals
were anesthetized with diethyl ether. The left hind paw was cleaned
with povidone iodine, and a 1-cm longitudinal incision (with a num-
ber 11 blade) was made through the skin and muscle of the plantar
aspect of the hind paw. After homeostasis with gentle pressure, the
skin was opposed with two mattress sutures of 5–0 nylon on HS-26
needle.
2.6. Rota-rod test
This test was used to rule out the possibility that the antinocicep-
tive actions of carbamazepine and morphine due to non-speciﬁc al-
terations of the animals' locomotive activity. Prior to investigation
of the antinociceptive effects of morphine and carbamazepine, the
doses of the each drug alone and in combination that did not cause
any signs of sedation or CNS depression were determined using the
rotarod test (Cartmell et al., 1991; Goodchild et al., 2008). The rate
of rotation was adjusted to allow the normal rats to stay on it for
180 s (7 rpm) for this apparatus (Ugo Basile, Model 7750, Italy).
Each rat was given ﬁve trials before the actual reading was taken.
The animals capable of staying on revolving rod for a period of
180 s before drug injection were selected and for evaluating the seda-
tion/ataxia induced by drugs to be studied. The test was repeated
30 min after drug injection. The mean time durations when animals
remained on the rotating bar for up to 180 s were compared among
groups and impaired motor coordination was determined
(Blackburn-Munro et al., 2002).
2.7. Evaluation of mechanical allodynia
Sensitivity to a mechanical stimulus was assessed with calibrated
von Frey ﬁlaments (Stoelting, Wood Dale, IL) (Li et al., 2007). Animals
were placed in individual plastic boxes on a wire ﬂoor and allowed to
acclimatize for 15 min. Von Frey ﬁlaments were applied to the plantar
surface of the hind foot and pressed to the point of bending over 6 s.
The ﬁlaments were applied in increasing order of bending force until
a brisk withdrawal or paw ﬂinching occurred (cut off=60 g). The
lower pawwithdrawal threshold (PWT) value obtained from 2 proce-
dures, spaced at 2-min intervals was used for analysis. Graphs (PWTs
vs times after injection) would be obtained in accordance to paw
withdrawal threshold (PWT) data. Then overall effects of treatments
were calculated by use of area under curve measurement (AUC) and
bigger AUC meant more analgesia. Investigation of the effect of test
compounds on mechanical allodynia was undertaken on surgery
day and day one post-incision.
2.8. Statistical analysis
The effects of drugs on the nociceptive threshold were evaluated
in a time course study as PWT, where each drug was administered
at the time zero and then area under curve (AUC) obtained with
Fig. 1. The effects of intraperitoneal injection of 3 mg/kg morphine, 5, 10 and 15 mg/kg
carbamazepine and co-administration on mechanical allodynia (n=6 per group) using
Area Under Curve data (obtained from PWT against time after drug administration
curve) on a rat model of postoperative pain inmorphine-dependent and naïve groups fol-
lowing drug injection on surgery day (day 0) and 24 h after surgery (day1).morph3:mor-
phine 3 mg/kg; cbz5, 10 and 15: carbamazepine 5, 10 and 15 mg/kg. Values are expressed
as mean±S.E.M. *Pb0.05 vs. naïve control; #Pb0.05 vs. morphine-dependent control.
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curves). All data were expressed as mean±S.E.M. (Standard Error of
the Mean).
One way analysis of variance (ANOVA) followed by Tukey's test,
was used for multiple comparison of vehicle-treated controls and
drug-treated groups with SPSS software. Differences at Pb0.05 were
considered signiﬁcant.
3. Results
3.1. Development of ataxia/sedation adverse effects of morphine and/or
carbamazepine
The main limitation of morphine or carbamazepine for clinical
uses is psychoactive side effects. Here, systemic daily treatment of an-
imals with 3 mg/kg morphine or 5, 10 and 15 mg/kg carbamazepine
was well tolerated by all rats as measured by endurance time on ro-
tating rod (Table 1), however, higher doses of carbamazepine and
co-administration of 3 mg/kg morphine with 10 or 15 mg/kg carba-
mazepine signiﬁcantly attenuated time duration and ability to control
motor coordination. Therefore, combination therapy was done only
with 3 mg/kg morphine and 5 mg/kg carbamazepine.
3.2. Anti allodynic effect of morphine and/or carbamazepine on postoper-
ative pain model
Intraplantar incision signiﬁcantly reduced the nociceptive PWT of
the incised hind paw, but there was no change in contralateral
thresholds of the nonincised hind paw throughout the experiment
period (data not shown). There was a signiﬁcant difference between
morphine-dependent and naïve controls in PWTs and AUC data dur-
ing the period of observation. AUC in naïve control was 67±4.62
and in morphine-dependent it changed to 29.92±1.34.
As shown in Fig. 1 morphine was less effective in morphine-
dependent rats than in naïve ones. Moreover, intraperitoneal admin-
istration of 5 mg/kg carbamazepine failed to ameliorate acute me-
chanical allodynia in naïve rats. In contrast, 10 and 15 mg/kg
carbamazepine produced a marked attenuation of mechanical allody-
nia throughout the observation period in both groups in accordance
to AUC data (Fig. 1). In fact, carbamazepine yielded a signiﬁcant ame-
liorating effect on allodynia over the whole treatment period in both
groups in a dose-dependent manner (Fig. 1). In addition, we assessedTable 1
Effect of i.p. administration of morphine and/or carbamazepine on motor coordination
by RotaRod test in naïve and morphine-dependent rats.
Group Time(s) S.E.M.
Naïve groups
Control, naïve 164.8 5.9
Morphine 3 mg/kg 153.8 11.3
Cbz 5 mg/kg 148.8 11.2
Cbz 10 mg/kg 151.4 12.3
Cbz 15 mg/kg 135.4 13.2
Cbz 5 mg/kg+morphine 3 mg/kg 144.8 8
Morphine-dependent groups
Control, morphine-dependent 159.4 6.5
Morphine 3 mg/kg 154.8 9.9
Cbz 5 mg/kg 153.8 9.1
Cbz 10 mg/kg 150.6 12.3
Cbz 15 mg/kg 148.8 10.1
Cbz 5 mg/kg+morphine3 mg/kg 139.2 11.5
Time(s) obtained from Rotarod test in naïve and morphine-dependent rats after i.p. in-
jection of vehicles (Control), carbamazepine (5, 10 and 15 mg/kg), and morphine
(3 mg/kg). The motor response or sedation was recorded 30 min after drug treatment
up 180 s. Neither morphine 3 mg/kg nor carbamazepine (up to 15 mg/kg) signiﬁcantly
affected the motor response of animals as compared with control group (Pb0.05). Sta-
tistical differences vs. control group were calculated using ANOVA, cbz: carbamaze-
pine; S.E.M.: standard error of mean.the antiallodynic effect of 3 mg/kg morphine co-administered with
5 mg/kg carbamazepine by AUC of PWT versus time after treatment
and interestingly this combination therapy signiﬁcantly increased
total AUC (on both days) in naïve and morphine-dependent groups
to 181±12.65 and 254±21.4 respectively.
3.3. Effect of morphine and/or carbamazepine on PWT after surgery in
naïve rats
In a second set of analysis, we investigated time course of drug in-
duced antinociception in a rat model of postoperative pain in naïve
rats (Fig. 2A,B). As mentioned earlier, we applied daily injections of
the drugs for 2 days starting at 2 h after surgery and monitored
PWTs every 30 min up to 3 h after surgery.
Results of the analysis of postoperative pain using von Frey ﬁla-
ment test showed a signiﬁcant difference in PWT in naïve rats be-
tween day 0 and day 1 post surgery (Fig. 2A and B). In general,
PWTs at day 1 were higher than day 0 in all groups.
Fig. 2A shows that in animals receiving 3 mg/kg morphine PWT
signiﬁcantly increased at 0.5, 1 and 1.5 h after injection on the surgery
day and then returned to the control value. In contrast, 5 mg/kg car-
bamazepine failed to have signiﬁcant antiallodynic effects at day
0 in naïve animals while combination therapy with 3 mg/kg mor-
phine and 5 mg/kg carbamazepine was as effective as morphine
alone.
Fig. 2B shows signiﬁcant analgesic effects of 3 mg/kg morphine
from 0.5 to 2.5 h after injection at day1 after surgery in naïve rats.
5 mg/kg carbamazepine did not exert antiallodynic effect on day 1
after surgery in naïve rats; however, co-administration with 3 mg/
kg morphine was as effective as morphine alone in increasing the
PWT.
3.4. Effect of morphine and/or carbamazepine on PWT after surgery in
morphine-dependent rats
PWTs in morphine-dependent groups are illustrated in Fig. 3A and
B at surgery day (day 0) and day after respectively. As shown in
Fig. 3A, 3 mg/kg morphine or 5 mg/kg carbamazepine administration
in morphine-dependent rats signiﬁcantly increased PWTs until 1 h
after drug injection at surgery day while this antiallodynic effect
was present only 0.5 h following treatment at day 1 for both drugs
alone (Fig. 3B). Surprisingly, co-administration of 3 mg/kg morphine
with 5 mg/kg carbamazepine markedly attenuated the mechanical
allodynia in morphine-dependent rats (Fig. 3A) in all time points at
day 0. Similar effects were observed with the treatments at day 1
(Fig. 3B). Therefore, combination therapy caused effective long term
reversal of allodynia in dependent rats.
Fig. 2. Time course of the effect of intraperitoneal administration of 3 mg/kg morphine and/or 5 mg/kg carbamazepine on mechanical allodynia in a rat model of postoperative pain
(n=6 per group). Paw withdrawal thresholds (PWT) are plotted against the time after injection of the agents in naïve groups. (A) shows mechanical allodynia surgery day (day 0)
and (B) illustrates mechanical allodynia 24 h after surgery (day 1). morph3: morphine 3 mg/kg; cbz5: carbamazepine 5 mg/kg, cbz5+morph3: combination therapy; N: naïve rats.
Results are expressed as mean±S.E.M. *Pb0.05 morphine group vs. control; #Pb0.05 combination therapy vs. control.
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Postoperative pain management in patients with previous con-
sumption or abuse of opioids, presents a complex problem regarding
drug therapy (Rapp et al., 1995). There has been a growing interest in
the potential utility of anticonvulsant drugs in the treatment of per-
sistent pain. The present study therefore attempted to directly inves-
tigate the analgesic effect of carbamazepine or/and morphine in
morphine-dependent and naïve rats on postoperative pain behaviors.
Combination therapy was performed with 3 mg/kg morphine and
5 mg/kg carbamazepine, due to sedative/ataxic effect of higher
doses of carbamazepine plus morphine.
No rat in this study responded to the highest force applied to the
hind paw skin before incision but they all responded to the lower
pressures after the incision, indicating that the incision produced me-
chanical allodynia, i.e., pain due to the stimuli that are not normally
painful. Signiﬁcant difference between morphine-dependent and
naïve rats that received vehicle in PWTs and AUC data over the period
of observation conﬁrms higher pain sensitivity of dependent rats.
Morphine or carbamazepine signiﬁcantly reduced mechanical
allodynia, as compared to controls except for 5 mg/kg carbamazepine
in naïve rats. This effect was dose-dependent with the greatest effect
observed at the highest dose of carbamazepine. Numerous studies
have veriﬁed the efﬁcacy of morphine in the rat model of postopera-
tive pain (Wang et al., 2000; Whiteside et al., 2004) because opioids
modulate transmission of pain sensation in the spinal cord by de-
creasing the signal relayed from peripheral to central pain pathways
and also alter the central perception of painful stimuli (Golan et al.,
2007). Nevertheless, 3 mg/kg morphine was less effective in mor-
phine-dependent rats on postoperative pain, suggesting that mor-
phine alone could not produce an antiallodynic effect on the
incisional pain in the rats rendered morphine-dependent with ourFig. 3. Time course of the effect of intraperitoneal administration of 3 mg/kg morphine and/o
(n=6 per group). Paw withdrawal thresholds (PWT) are plotted against the time after in
surgery day (day 0) and (B) illustrates mechanical allodynia 24 h after surgery (day 1). Co-a
PWT throughout observation in morphine-dependent rats in postoperative pain model. mo
therapy; M: morphine-dependent rats. Results are expressed as mean±S.E.M. *Pb0.05 mor
tion therapy vs. control.protocol. Thus, it is conceivable that morphine tolerance occurs in
morphine-dependent rats.
In case of carbamazepine, it has been associated with different
mechanisms of action which, either individually or in combination,
could be responsible for postoperative pain management. The antiallo-
dynic action of carbamazepine could be explained by its proven block of
voltage dependent sodium channels leading to stabilization of the pre-
synaptic neuronal membrane and ﬁnally reduction in both neurotrans-
mitter release (Zullino et al., 2004) and action potential conduction in
nociceptive ﬁbers (Catterall, 1987). Moreover, carbamazepine has
been reported to interrupt glutamatergic function via N-methyl-D-as-
partate (NMDA) receptor and, consequently, modulate central sensiti-
zation induced by the incision (Decosterd et al., 2004; Gilron, 2006).
In addition, carbamazepine has been shown to be efﬁcacious in acute
and chronic pain management, treatment of trigeminal neuralgia and
diabetic neuropathy (Campbell et al., 1966; Golan et al., 2007; Wiffen
et al., 2011). Furthermore, carbamazepine had analgesic effects in the
formalin test (Campbell et al., 1966) and demonstrated anti-
inﬂammatory effect following postoperative pain (Bianchi et al., 1995).
Finally, co-administration of carbamazepine with morphine in
morphine-dependent rats experiencing postoperative pain interest-
ingly exerted effective and long term analgesia. Given the limited ef-
ﬁcacy of any single drug administration and the multiple sites of
action for analgesics, it is common in clinical practice to beneﬁt
from a drug combination approach in managing pain in order to ob-
tain additive or supra-additive effects (Golan et al., 2007; Shannon
et al., 2005). The observed effect of carbamazepine on postoperative
pain in dependent animals suggests a direct action of this agent on
morphine analgesia and conﬁrms the ability of anticonvulsant admin-
istration in enhancing opioid analgesia or suppressing mechanisms of
opioid tolerance as previously described (Gilron, 2006) and support
opioid sparing effect of carbamazepine (Zullino et al., 2004).r 5 mg/kg carbamazepine on mechanical allodynia in a rat model of postoperative pain
jection of the agents in morphine-dependent rats. (A) shows mechanical allodynia on
dministration of 3 mg/kg morphine and 5 mg/kg carbamazepine signiﬁcantly increased
rph3: morphine 3 mg/kg; cbz5: carbamazepine 5 mg/kg, cbz5+morph3: combination
phine group vs. control; $Pb0.05 carbamazepine group vs. control; #Pb0.05 combina-
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pine, these ﬁnding are consistent with studies which showed that
NMDA receptor antagonists enhanced the antinociceptive effect of
morphine (Sepúlveda et al., 2002; Wong et al., 1996). In addition,
Pakulska reported that single administration of oxcarbamazepine en-
hanced the antinociceptive effect of morphine and led to a decrease in
morphine tolerance in the hot plate test (Pakulska and Czarnecka,
2009) although Li et al. (2004) showed the inefﬁcacy of carbamaze-
pine on morphine tolerance in mice (Contreras et al., 1977). Such dis-
crepancies can be due to the differences in protocols such as acute or
chronic drug administration and test assessments (Chesler et al.,
2002).
In morphine tolerance or dependence states, chronic administra-
tion of morphine up-regulates cyclic adenosine monophosphate
(cAMP) which, in turn, stimulates protein kinase A (PKA), that phos-
phorylates and thereby activates both cAMP and voltage-gated sodi-
um channels (Golan et al., 2007). Therefore, results of this study
demonstrates that carbamazpine as a sodium channels blocker
would block up-regulated sodium channels in morphine-
dependency, and could decrease development of morphine tolerance
or enhance and prolong morphine analgesia on incised rats. Further
research is needed to identify the mechanism of action of carbamaz-
epine in morphine dependency or tolerance.
5. Conclusion
Carbamazepine is an effective agent on postoperative pain man-
agement in naïve and morphine-dependent rats. In addition, result
of combination therapy is potentially very useful clinically because
many types of pain cannot be effectively treated with single agents
such as morphine because of dose-related side effects and carbamaz-
epine would potentiate and prolong the analgesic effect of chronically
administered morphine on postoperative pain model in morphine-
dependent rats.
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